Medtronic 2015 Annual Report Download - page 80
Download and view the complete annual report
Please find page 80 of the 2015 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70 -
71 -
72 -
73 -
74 -
75 -
76 -
77 -
78 -
79 -
80 -
81 -
82 -
83 -
84 -
85 -
86 -
87 -
88 -
89 -
90 -
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
 |
 |
Medtronic plc
Consolidated Statements of Shareholders’ Equity
Ordinary Shares Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Shareholders’
EquityNumber Par Value
(in millions)
Balance as of April 27, 2012 1,037 $ 104 $ 17,482 $ (473) $ 17,113
Net income — — 3,467 — 3,467
Other comprehensive loss — — — (19) (19)
Dividends to shareholders — — (1,055) — (1,055)
Issuance of shares under stock purchase and award plans 10 1 266 — 267
Repurchase of ordinary shares (31) (3) (1,244) — (1,247)
Tax deficit from exercise of stock-based awards — — (7) — (7)
Stock-based compensation — — 152 — 152
Balance as of April 26, 2013 1,016 $ 102 $ 19,061 $ (492) $ 18,671
Net income — — 3,065 — 3,065
Other comprehensive loss — — — (105) (105)
Dividends to shareholders — — (1,116) — (1,116)
Issuance of shares under stock purchase and award plans 31 3 1,304 — 1,307
Repurchase of ordinary shares (48) (5) (2,548) — (2,553)
Tax benefit from exercise of stock-based awards — — 29 — 29
Stock-based compensation — 145 — 145
Balance as of April 25, 2014 999 $ 100 $ 19,940 $ (597) $ 19,443
Net income — — 2,675 — 2,675
Other comprehensive loss — — — (587) (587)
Ordinary shares issued in connection with the Covidien plc
acquisition, net of taxes 436 — 33,787 — 33,787
Result of contribution of Medtronic, Inc. to Medtronic plc — (99) 99 — —
Dividends to shareholders — — (1,337) — (1,337)
Issuance of shares under stock purchase and award plans 17 2 647 — 649
Repurchase of ordinary shares (30) (3) (1,917) — (1,920)
Tax benefit from exercise of stock-based awards — — 81 — 81
Stock-based compensation — — 439 — 439
Balance as of April 24, 2015 1,422 $ — $ 54,414 $ (1,184) $ 53,230
The accompanying notes are an integral part of these consolidated financial statements.
70